CD158k/killer cell immunoglobulin-like receptor 3DL2 represents a specific marker for the evaluation of SC (16); in particular, CD4+ CD158k+ lymphocytes in blood from patients with SS correspond to the malignant clonal cell population (17). The gene discussed is KIR3DL2; the disease is synovial sarcoma.